Cardinal Health works with Americares, and McKesson with World Vision, to deliver supplies
One million product items, including masks, gowns, biohazard bags and shoe covers have been provided by Cardinal Health for use in Liberia and Sierra Leone, where current estimates are that as many as 1.4 million residents in the two countries might ultimately be affected. The donation, being handled in multiple shipments, is managed by Americares, Inc. (Stamford CT), which works with many US healthcare products manufacturers to provide emergency relief in the developing world following natural disasters and epidemics like the current Ebola crisis.
“As a company with concerns for the health and well-being of people around the world, we’re proud to be able to support international relief efforts in this way,” said Mike Duffy, president, Medical Products at Cardinal Health, in a statement, “and we’re glad to have a long-standing affiliation with organizations like AmeriCares that are able to quickly deploy products to the places they’re needed most.”
Another Big Three US wholesaler, McKesson, made a comparable relief contribution to World Vision, a Pittsburgh charitable organization, in mid-September, and a group of healthcare providers and manufacturers organized one in mid-August with Direct Relief. There have been press reports that relief contributions like these are being held up at airports and loading docks. An Americares spokesperson notes that the organization has representatives in place in Liberia and Sierra Leone to oversee distribution, and works with in-country relief organizations there to ensure the shipments get delivered.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.